ArticleLiver cancer2019

Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.

Tim A Labeur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.